Zhangzhou Pientzehuang Pharmaceutical | 600436 - Net Income

Stock Price
170.44
Daily Change
6.55 4.00%
Monthly
-0.65%
Yearly
-17.30%
Q1 Forecast
156.87

Zz Pientze Pharmaceu reported CNY687.04M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Alaunos Therapeutics USD -1.16M 417K Sep/2025
Avita Medical AUD -9.92M 1.67M Jun/2025
Cspc Pharmaceutical CNY 963.54M 106.35M Sep/2025
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Ionis Pharmaceuticals USD -128.61M 252.16M Sep/2025
IQVIA Holdings USD 514M 183M Dec/2025
Jiangsu Hengrui CNY 1.3B 1.27B Sep/2025
Kangmei Pharma CNY -3.82M 12.21M Sep/2025
Moderna USD -200M 625M Sep/2025
Revvity USD 46.65M 7.3M Sep/2025
Sh Fosun Pharma CNY 821.33M 115.88M Sep/2025
Tectonic Therapeutic USD -19.04M 940K Sep/2025
Viatris USD -128.2M 123.6M Sep/2025
Wuxi Apptec CNY 3.51B 1.39B Sep/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025
Zz Pientze Pharmaceu CNY 687.04M 244.51M Sep/2025